Novel venetoclax combination therapy advancing the field of CLL

In chronic lymphocytic leukemia (CLL), venetoclax has established itself as one of the most effective monotherapies in certain contexts. Speaking from the American Society of Hematology (ASH) 2017 Ann... Author: VJHemOnc Added: 12/15/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts